ClinicalTrials.Veeva

Menu

Simultaneously PET/MRI in Prolonged DOC Patients

H

Hangzhou Normal University

Status

Completed

Conditions

Minimally Conscious State
Disorder of Consciousness
Rs-fMRI
FDG-PET

Treatments

Diagnostic Test: Multimodal Neuroimaging

Study type

Observational

Funder types

Other

Identifiers

NCT04164680
2019N55749

Details and patient eligibility

About

Recently introduced hybrid PET/MR scanners provide the opportunity to measure simultaneously, and in direct spatial correspondence, both metabolic demand and functional activity of the brain, hence capturing complementary information on the brain's physiological state. Here we exploited PET/MR simultaneous imaging to explore the relationship between the metabolic information provided by resting-state fluorodeoxyglucose-PET (FDG-PET) and fMRI (rs-fMRI) in patients with disorders of consciousness.

Enrollment

24 patients

Sex

All

Ages

16 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • DOC patients (acute, subacute or chronic period): Coma, UWS and MCS.

Exclusion criteria

  • neuromuscular blocking agents or sedative drugs administered within the prior 24 hours;
  • unstable medical condition;
  • mental implant in the brain

Trial design

24 participants in 1 patient group

Patients with disorders of consciousness
Treatment:
Diagnostic Test: Multimodal Neuroimaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems